These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 35904817

  • 1. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism.
    Dai W, Xiang W, Han L, Yuan Z, Wang R, Ma Y, Yang Y, Cai S, Xu Y, Mo S, Li Q, Cai G.
    Cancer Commun (Lond); 2022 Sep; 42(9):848-867. PubMed ID: 35904817
    [Abstract] [Full Text] [Related]

  • 2. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
    Li J, Huang Q, Long X, Zhang J, Huang X, Aa J, Yang H, Chen Z, Xing J.
    J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Deficiency of SDHC promotes metastasis by reprogramming fatty acid metabolism in colorectal cancer.
    Ding Z, Wei Y, Dai J, Pan C, Yang L, Li Q, Zhang Y, Yan Q, Wu C, Li A, Lan Z, Liu S, Wang X.
    J Transl Med; 2024 Jun 06; 22(1):544. PubMed ID: 38844980
    [Abstract] [Full Text] [Related]

  • 5. PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis.
    Zhang W, Hou J, Wang X, Jiang R, Yin Y, Ji J, Deng L, Huang X, Wang K, Sun B.
    Oncotarget; 2015 Apr 20; 6(11):9420-33. PubMed ID: 25826083
    [Abstract] [Full Text] [Related]

  • 6. RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4.
    Wang C, Chen Z, Yi Y, Ding Y, Xu F, Kang H, Lin K, Shu X, Zhong Z, Zhang Z, Liu J, Xu Z, Liu L, He X, Chang Y, Zhao Q.
    Oncogene; 2024 Jan 20; 43(5):328-340. PubMed ID: 38040804
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genistein Regulates Lipid Metabolism via Estrogen Receptor β and Its Downstream Signal Akt/mTOR in HepG2 Cells.
    Qin H, Song Z, Shaukat H, Zheng W.
    Nutrients; 2021 Nov 10; 13(11):. PubMed ID: 34836271
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
    Kong Q, Zhang H, Zhao T, Zhang W, Yan M, Dong X, Li P.
    Int J Mol Med; 2016 Dec 10; 38(6):1715-1726. PubMed ID: 27840945
    [Abstract] [Full Text] [Related]

  • 15. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J, Zhao X, Jiang H, Yang T, Li D, Yang X, Jia A, Ma Y, Qian Z.
    Tissue Cell; 2022 Aug 10; 77():101817. PubMed ID: 35679685
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oncolytic avian reovirus σA-modulated fatty acid metabolism through the PSMB6/Akt/SREBP1/acetyl-CoA carboxylase pathway to increase energy production for virus replication.
    Hsu CY, Chen YH, Huang WR, Huang JW, Chen IC, Chang YK, Wang CY, Chang CD, Liao TL, Nielsen BL, Liu HJ.
    Vet Microbiol; 2022 Oct 10; 273():109545. PubMed ID: 35998542
    [Abstract] [Full Text] [Related]

  • 18. Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice.
    Pan Q, Qin T, Gao Y, Li S, Li D, Peng M, Zhai H, Xu G.
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar 01; 1865(3):525-534. PubMed ID: 30562559
    [Abstract] [Full Text] [Related]

  • 19. The ménage à trois of autophagy, lipid droplets and liver disease.
    Filali-Mouncef Y, Hunter C, Roccio F, Zagkou S, Dupont N, Primard C, Proikas-Cezanne T, Reggiori F.
    Autophagy; 2022 Jan 01; 18(1):50-72. PubMed ID: 33794741
    [Abstract] [Full Text] [Related]

  • 20. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.
    Zhang W, Liu Y, Yan Z, Yang H, Sun W, Yao Y, Chen Y, Jiang R.
    J Immunother Cancer; 2020 Jun 01; 8(1):. PubMed ID: 32581055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.